Literature DB >> 9177232

A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis.

G J Nau1, P Guilfoile, G L Chupp, J S Berman, S J Kim, H Kornfeld, R A Young.   

Abstract

Chronic inflammation and granuloma formation are associated with mononuclear cell infiltrates and are characteristic pathologic responses in tuberculosis. To identify host cell genes involved in tuberculous pathology, we screened macrophage cDNA libraries for genes induced by mycobacterial infection. One gene isolated in this screen, osteopontin (also known as early T lymphocyte activation protein 1 or Eta-1), was of particular interest because it is a cytokine and macrophage chemoattractant. Further study revealed that Mycobacterium tuberculosis infection of primary human alveolar macrophages causes a substantial increase in osteopontin gene expression. Osteopontin protein was identified by immunohistochemistry in macrophages, lymphocytes, and the extracellular matrix of pathologic tissue sections of patients with tuberculosis. Increased osteopontin expression also was found to be associated with silicosis, another granulomatous disease. The association of osteopontin with granulomatous pathology, together with the known properties of the protein, suggest that osteopontin may participate in granuloma formation. The strategy of identifying host genes whose expression is altered by infection thus can provide valuable clues to disease mechanisms and will be increasingly valuable as additional human genome sequences become available.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177232      PMCID: PMC21064          DOI: 10.1073/pnas.94.12.6414

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Effect of recombinant osteopontin on adhesion and migration of P388D1 cells.

Authors:  S Yamamoto; K Nasu; T Ishida; M Setoguchi; Y Higuchi; N Hijiya; S Akizuki
Journal:  Ann N Y Acad Sci       Date:  1995-04-21       Impact factor: 5.691

2.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.

Authors:  C M Giachelli; N Bae; M Almeida; D T Denhardt; C E Alpers; S M Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

4.  Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.

Authors:  S Hirota; M Imakita; K Kohri; A Ito; E Morii; S Adachi; H M Kim; Y Kitamura; C Yutani; S Nomura
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

5.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

6.  Macrophages express osteopontin during repair of myocardial necrosis.

Authors:  C E Murry; C M Giachelli; S M Schwartz; R Vracko
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  Detection and characterization by differential PCR of host eukaryotic cell genes differentially transcribed following uptake of intracellular bacteria.

Authors:  W R Schwan; S Kügler; S Schüller; D J Kopecko; W Goebel
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin.

Authors:  S Beninati; D R Senger; E Cordella-Miele; A B Mukherjee; I Chackalaparampil; V Shanmugam; K Singh; B B Mukherjee
Journal:  J Biochem       Date:  1994-04       Impact factor: 3.387

Review 10.  Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene.

Authors:  R Patarca; R A Saavedra; H Cantor
Journal:  Crit Rev Immunol       Date:  1993       Impact factor: 2.214

View more
  44 in total

1.  Fibrogenic and redox-related but not proinflammatory genes are upregulated in Lewis rat model of chronic silicosis.

Authors:  Raymond J Langley; Neerad C Mishra; Juan Carlos Peña-Philippides; Brandon J Rice; Jean-Clare Seagrave; Shashi P Singh; Mohan L Sopori
Journal:  J Toxicol Environ Health A       Date:  2011

2.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection.

Authors:  V Khajoee; M Saito; H Takada; A Nomura; K Kusuhara; S-I Yoshida; Y Yoshikai; T Hara
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Distinct immunohistochemical expression of osteopontin in the adult rat major salivary glands.

Authors:  Nicholas Obermüller; Nikolaus Gassler; Norbert Gretz; Bettina Kränzlin; Sigrid Hoffmann; Helmut Geiger; Stefan Gauer
Journal:  J Mol Histol       Date:  2006-07-03       Impact factor: 2.611

5.  Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis.

Authors:  A M Talaat; R Reimschuessel; S S Wasserman; M Trucksis
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

Authors:  Takashi Nomiyama; Diego Perez-Tilve; Daisuke Ogawa; Florence Gizard; Yue Zhao; Elizabeth B Heywood; Karrie L Jones; Ryuzo Kawamori; Lisa A Cassis; Matthias H Tschöp; Dennis Bruemmer
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma.

Authors:  Masatsugu Kurokawa; Satoshi Konno; Satoshi Matsukura; Mio Kawaguchi; Koushi Ieki; Shintarou Suzuki; Miho Odaka; Shin Watanabe; Tetsuya Homma; Masayuki Sato; Hiroko Takeuchi; Takashi Hirose; Shau-Ku Huang; Mitsuru Adachi
Journal:  Int Arch Allergy Immunol       Date:  2009-06-03       Impact factor: 2.749

10.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.